Discover Community Create You

Loading publication...

Noodle always counts identifier-free feature events for service operation. With your permission, Google Analytics can also estimate audience and engagement. Search text, publication identifiers, cookies, IP addresses and browser fingerprints are never included in Noodle's first-party event counters.

Privacy details

Article

Invasive ductal carcinoma of the breast with the "triple-negative" phenotype: prognostic implications of EGFR immunoreactivity.

Breast cancer research and treatment - 1 Jul 2009

Viale Giuseppe, Rotmensz Nicole, Maisonneuve Patrick, Bottiglieri Luca, Montagna Emilia, Luini Alberto, Veronesi Paolo, Intra Mattia, Torrisi Rosalba, Cardillo Anna, Campagnoli Elisabetta, Goldhirsch Aron, Colleoni Marco

Abstract excerpt

Invasive ductal carcinomas (IDC) of the breast with the triple negative phenotype (steroid hormone receptor absent, negative HER2 status) are characterized by poor clinical outcome. Additional tumor markers might allow identification of patients at higher risk. We evaluated clinical and biological features of 284 consecutive patients with pT1-3, pN1-3 M0 triple-negative IDC. Median follow-up was 70 months...

Read the complete abstract on PubMed

Topics

Share this publication in a Topic to start or enrich a Post.

Share to Carcinoma, Ductal, Breast
Share to Chemotherapy, Adjuvant

Methodology Data sources Editorial policy Privacy About Contact Helena Bioinformatics

Share to Combined Modality Therapy

Share to Mastectomy

Share to Radiotherapy

Share to Receptor, ErbB-2

Share to Receptors, Estrogen

Share to Receptors, Progesterone

Source

Identifiers

PMID: 18839307
DOI: 10.1007/s10549-008-0206-z

Genes

EGFR

Provenance

PubMed metadata and Literature Corpus relationships. Corpus snapshot updated 7 Sept 2026. Manifest publication-graph-cohort-2026-09-07.1.

Source receipt: pubmed, retrieved 7 Sept 2026.

Related research

Semantic proximity does not establish scientific evidence.

Research trail→

Click a neighbor to travelStep 1 · 12 closest

Invasive ductal carcinoma of the breast with the "triple-negative" phenotype: prognostic implications of EGFR immunoreactivity.PMID 18839307Read ↗

Prognostic markers in triple-negative breast cancer.Semantic proximity Read ↗

Descriptive analysis of estrogen receptor (ER)-negative, progesterone receptor (PR)-negative, and HER2-negative invasive breast cancer, the so-called triple-negative phenotype: a population-based study from the California cancer Registry.Semantic proximity Read ↗

Prognostic Evaluation of Epidermal Growth Factor Receptor (EGFR) Genotype and Phenotype Parameters in Triple-negative Breast Cancers.Semantic proximity Read ↗

Triple-negative Breast Carcinoma: Morphologic and Molecular Subtypes.Semantic proximity Read ↗

Impact of triple negative phenotype on breast cancer prognosis.Semantic proximity Read ↗

Prognostic impact of clinicopathologic parameters in stage II/III breast cancer treated with neoadjuvant docetaxel and doxorubicin chemotherapy: paradoxical features of the triple negative breast cancer.Semantic proximity Read ↗

Epidermal growth factor receptor expression in breast cancer association with biologic phenotype and clinical outcomes.Semantic proximity Read ↗

Quantitative immunocytochemical profile to predict early outcome of disease in triple-negative breast carcinomas.Semantic proximity Read ↗

Prognostic impact of PIK3CA protein expression in triple negative breast cancer and its subtypesSemantic proximity Read ↗

Prognostic impact of triple negative phenotype in conservatively treated breast cancer.Semantic proximity Read ↗

Prognostic value of androgen receptor and FOXA1 co-expression in non-metastatic triple negative breast cancer and correlation with other biomarkers.Semantic proximity Read ↗

Phenotypic characterization of circulating tumor cells in triple negative breast cancer patients.Semantic proximity Read ↗

⌁Select a neighboring publication to make it the new centre.